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In the last few years there has been a growing interest in the use 
of machine learning algorithms for analyzing fMRI data. Machine 
learning algorithms can be used to train classifiers to decode stimuli, 
behaviors and other variables of interest from fMRI data (Haynes and 
Rees, 2006; O’Toole et al., 2007; Pereira et al., 2009). Demirci applied a 
projection pursuit technique to components obtained via independ-
ent component analysis (ICA) of fMRI activation maps, to classify 
individuals as being either schizophrenia patients or healthy controls 
(Demirci et al., 2008). Shinkareva et al. (2006) presented a unified 
feature selection and classification procedure to classify subjects into 
groups based on four dimensional spatio-temporal data. Zhang et al. 
(2005) applied the adaptive boosting algorithm (AdaBoost) (Freund 
and Schapire, 1997) to classify subjects into groups (drug-addicted 
subjects and healthy non-drug-using controls) based on the observed 
3D brain images. Ford et al. (2003) used a Fisher linear discriminant 
analysis on the fMRI brain activation maps to extract spatial charac-
teristics and to classify healthy controls versus patients with schizo-
phrenia, Alzheimer’s disease, and mild traumatic brain injury.
To date, limited work has been done on the use of genotypic 
information to help classify patients from controls, although Struyf 
et al. (2008) demonstrated that SVMs can distinguish bipolar and 
schizophrenia from normal control with a high accuracy by comb-
ing gene expression data with demographic and clinical data.
IntroductIon
Schizophrenia is a severe, chronic, brain disease that disrupts normal 
thinking, speech, and behavior. Schizophrenia diagnosis currently 
relies on clinical examination and the illness course, with many 
subcategories reflecting different aspects of this complex and likely 
biologically heterogeneous mental disease. Despite the diagnostic 
reliability achieved by quantifiable examination of overt psychiatric 
symptoms, researchers have also used biological indices in attempts 
to classify schizophrenia patients (Murray et al., 1992; Malaspina 
et al., 1998; Sponheim et al., 2001, 2003). Recently, there have been 
increasing efforts to utilize brain functional magnetic resonance 
imaging (fMRI) and examine genetic variation to study potential 
schizophrenia biomarkers, in order to better understand the pathol-
ogy of schizophrenia. While most such studies focus on identifying 
associations between genetics and brain function in schizophrenia, 
we look at this problem from a different perspective, using biological 
and genetic information to help classify the disorder. We attempt to 
improve classification accuracy and provide preliminary data, suggest-
ing that by combining biological and genetic information, we can best 
reflect the underlying pathophysiology, which ultimately may aid in 
the diagnosis of schizophrenia and its subcategories. We also predict 
that by achieving better classification, intrinsic connections between 
genetic variation and biological function can also be identified.
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Many researchers now agree that schizophrenia may develop 
as a result of interplay between genetic predisposition (for 
example, inheriting certain susceptibility genes) and environ-
mental exposure. While genetic factors play an important role 
in  schizophrenia – persons who have immediate relatives with 
a history of schizophrenia have a significantly increased risk for 
developing the disorder over that of the general population. 
However, even monozygotic twins have only about 42% con-
cordance for the disease (Lee et al., 2005). Environmental factors 
may well lead to subtle brain alterations that increase the risk of 
schizophrenia. Thus combining fMRI data (which captures brain 
function presumably reflecting both genetic and environmen-
tal influences) with genetic information, is potentially a useful 
way to help classify schizophrenia (Hariri and Weinberger, 2003; 
Pearlson and Folley, 2008; Calhoun et al., 2009; Liu et al., 2009; 
Potkin et al., 2009).
In this paper we present a supervised machine learning method 
to classify schizophrenia and control individuals that incorporates 
fMRI and SNP data. The method to fuse information from both 
modalities comprises four stages. At the first stage, a support vector 
machine based classifier ensemble (SVME) is constructed by using 
signature SNPs selected from a large SNP pool (SNP-SVME). At 
the second stage, a SVME is trained with a subset of voxels (Voxel-
SVME). At the third stage, fMRI activation components obtained 
with ICA are used to construct a single SVM classifier (ICA-SVMC). 
Finally, at the fourth state the results obtained from the above three 
stages are combined into a single module using majority voting 
(Combined SNP-fMRI). We will first explain the data collection 
and preparation procedures, and describe the proposed method 
in detail. Then, we present the experimental results, followed by 
discussion and conclusion.
data and ExpErImEnts
subjEcts
We investigated fMRI and SNP data from 40 subjects, 20 schizo-
phrenia patients (age: 40.2 ± 9.8, three females) and 20 healthy 
controls (age 42.5 ± 15.5, eight females). All participants pro-
vided written, informed, IRB-approved consent at Hartford 
hospital. Patients met criteria for DSM-IV-TR schizophrenia 
based on the structured clinical interview for DSM IV (SCID; 
First et al., 1995) and review of the case file by a clinician. Healthy 
subjects were screened to ensure they were free from DSMIV Axis 
I or Axis II psychopathology assessed using the SCID (Spitzer 
et al., 1996) and also interviewed to determine that there was 
no history of psychosis in any first-degree relative. All selected 
subjects were Caucasian/non-Hispanic. Twenty chronic SZ 
patients were selected and 16 of them had available, contem-
poraneous positive and negative syndrome scale (PANSS) scores 
(Kay et al., 1987). For those 16 SZ patients, PANSS total score 
was 67.6 ± 30.0 (mean ± SD), positive symptom score 15.4 ± 4.1, 
and negative symptom score 14.5 ± 6.7. Seventeen SZ patients 
had available medication information. These were taking 26 
types of first and second-generation antipsychotics in variable 
doses, with most patients taking more than one such drug. The 
most commonly prescribed medicines included olanzapine, 
risperidone, quetiapine, haloperidol, divalproex, escitalopram, 
and aripiprazole.
snp data collEctIon and prEprocEssIng
A saliva sample was obtained for each subject and DNA extracted. 
Genotyping was performed using the Illumina BeadArray™ plat-
form and the GoldenGate™ assay (Oliphant et al., 2002; Fan et al., 
2003). The PG Array of Genomas Inc. was used (the detailed com-
position has been published as a patent application, Ruano, 2006). 
The SNP array consists of 384 SNPs from 222 genes derived from 
six physiological systems: neurobiology, metabolism, cell prolifera-
tion, cardiovascular, inflammation, and cholesterol biochemistry. 
Over all systems, the following pathways were represented: insu-
lin resistance, glucose metabolism, energy homeostasis, adiposity, 
apolipoproteins and receptors, fatty acid and cholesterol metabo-
lism, lipases, receptors, cell signaling and transcriptional regulation, 
growth factors, drug metabolism, blood pressure, vascular signal-
ing, endothelial dysfunction, coagulation and fibrinolysis, vascular 
inflammation, cytokines, and behavior (satiety).
Genotyping analysis software, GenCall, was used to cluster the 
intensities from the genotyping microarray into three clusters: 
AA, AB, and BB, without assuming dominant or recessive inherit-
ance. On the basis of the GenCall score, a number between 0 and 
1 indicating how close to the center of the cluster a sample lies, we 
chose a threshold to select only reliable genotype results. SNPs with 
a GenCall score of 0.25 or higher were selected, resulting in 367 
SNPs. Genotypes are inherently categorical and can be represented 
as discrete numbers, e.g., 1 for one type of homozygous, 0 for het-
erozygous, and −1 for the other type of homozygous. In our study, 
each subject has a feature vector with 367 discrete numbers.
fmrI data collEctIon and prEprocEssIng
FMRI data were collected during performance of an auditory odd-
ball task (Kiehl and Liddle, 2003), which consists of detecting an 
infrequent sound within a series of frequent sounds. The same audi-
tory stimuli were used and found to be effective in eliciting fMRI 
BOLD patterns differentiating healthy controls from schizophrenia 
subjects (Kiehl et al., 2005). Auditory stimuli were presented to 
each participant by a computer stimulus presentation system via 
earphones. Subjects were presented with three types of sounds: 
target (1000 Hz with probability p = 0.1), novel (non-repeating 
random digital noises, p = 0.1), and standard (500 Hz, p = 0.8). 
Subjects were expected to respond and press a button with their 
right index finger every time they heard a target stimulus and not 
to respond to standard or novel sounds.
Scans were acquired at the Olin Neuropsychiatry Research 
Center at the Institute of Living on a Siemens Allegra 3 T dedi-
cated head MRI scanner equipped with 40 mT/m gradients 
and a standard quadrature head coil. The functional scans were 
acquired using gradient-echo echo-planar-imaging with the fol-
lowing parameters (repeat time = 1.50 s, echo time = 27 ms, field of 
view = 24 cm, acquisition matrix = 64 × 64, flip angle = 70°, voxel 
size = 3.75 × 3.75 × 4 mm3, slice thickness = 4 mm, gap = 1 mm, 
29 slices, ascending acquisition).
Six “dummy” scans were performed at the beginning to allow 
for longitudinal equilibrium, after which the paradigm was auto-
matically triggered to start by the scanner. Data were preprocessed 
using the software package SPM2 (http://www.fil.ion.ucl.ac.uk/
spm/). Images were realigned using INRIalign – a motion cor-
rection algorithm unbiased by local signal changes (Freire and 
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a SVME by a feature selective AdaBoost method (FSA) (Howe, 
2003). The second stage is to construct a SVME for fMRI images 
with the optimal subset of voxels to reach the best classification 
performance. We first average neighboring voxels to reduce com-
putation complexity, and then construct a SVME using the FSA on 
the averaged voxels. The third stage is to obtain a SVM classifier 
using independent components extracted from fMRI activation 
maps by ICA. The fourth and final stage is to combine the three 
classification models obtained from above stages into one model 
using majority voting.
snps subsEt sElEctIon and sVmE
Classifying schizophrenia based on genetic data is complicated 
by small-sample-size classification problems (Fukunaga, 1990). 
Genetic data have high dimensionality compared to the generally 
small number of available subject samples. The dimensionality N 
is often considered large if it is in the range of hundreds. Genetic 
data, however, can have hundreds of thousands of dimensions 
(genes or loci). Some genes are related to the schizophrenia clas-
sification task, but many are presumably irrelevant. The learning 
algorithms can be potentially confused by the irrelevant/redundant 
features and construct poor classifiers (Jain and Chandrasekaran, 
1982). To address the small-sample-size classification problem, we 
propose a two-step algorithm to select informative genes from a 
high-dimensional space and generate a classifier ensemble through 
SVM. The first step is a filter that removes most irrelevant features 
and selects a candidate SNP subset from whole SNP pool using 
FSFS. The second step combines a SNP selection into AdaBoost 
SVM ensemble algorithm to construct SVME with signature 
SNP subset.
Mangin, 2001). Data were spatially normalized into the standard 
Montreal Neurological Institute space (Friston et al., 1995), resliced 
to 3 × 3 × 3 mm3, and spatially smoothed with a 10 × 10 × 10 mm3 
Gaussian kernel. Data for each participant were analyzed by mul-
tiple regression incorporating regressors for the novel, target, and 
standard and their temporal derivatives plus an intercept term. The 
target-related contrast images were used in this study. Finally, we 
used a mask based upon one-sample t-test against zero activation 
to select meaningful voxels. This results in a size of 7,060 voxels in 
each fMRI image.
mEthods
thE hybrId machInE lEarnIng mEthod
A two-class supervised learning problem can be written as a formula,
X x= ( ) ∈ ∈ − +{ } ={ }i i i d iy y i m, , , , , , , , ,x R 1 1 1 2   with m 
samples (subjects in this study). Each sample x
i
 has d features and 
a class label y
i
. From a set of training samples, the machine learning 
algorithm establishes a classifier, which represents a hypothesis, h. 
Given unseen samples, the classifier predicts the corresponding y 
value. An ensemble method constructs a set of classifiers {h
1
, …, h
T
}, 
chooses a set of weights {α
1
, …, α
T
} and build a weighted average 
classifier H(x) = α
1
h
1
(x) + … α
T
h
T
(x). The classification decision of 
the combined classifier H is +1 if H(x) > 0 and −1 otherwise.
The flowchart of the proposed supervised machine learning 
method can be seen in Figure 1. There are four stages to fuse 
fMRI and genetic data, and to classify schizophrenia. The first stage 
is to select signature SNP loci and construct a SVME for SNPs, 
termed SNP-SVME. Two steps are involved: (1) to select a subset 
of candidate SNPs from whole SNPs pool by the forward sequen-
tial feature selection method (FSFS) (Liu, 2005); (2) to construct 
Figure 1 | Flow chart of method.
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•	Output	the	final	classifier	ensemble:	H( ) sign h ( ) .*x = ( )=∑ at ttT x1
As shown above, the FSA algorithm runs for T iterations, and 
the final classification output of H is a weighted T individual clas-
sifiers. Initially, all weights of training samples are set equally. On 
each round the weights of misclassified samples are increased so 
that the algorithm forces classifiers to focus on those samples in 
the training set.
Furthermore, within each iteration cycle, the FSA algorithm 
ranks all features with training error rate, and selects l features 
with the lowest training error rate. The number l is decided based 
on the leave one out (LOO) SVMs performance with the weighted 
training samples used in this iteration. Thus the FSA algorithm 
selects the feature subset that contains the most discriminating 
information on each round and trains a classifier based on weighted 
training samples with the selected features. Accuracy and diversity 
of individual classifiers critically influence the classification per-
formance of ensemble methods. The FSA increases the diversity 
among the classifiers by allowing a flexible feature space, which in 
turn enhances the overall performance of SVME.
Valentini and Dietterich (2002) analyzed bias-variance decom-
position of the error in SVM, and showed that the bias-variance 
decomposition offers a rationale to develop ensemble methods 
using SVMs as base learners. In this paper, the kernel function of 
SVM is the radial basis function (RBF) kernel. SVM is a statistical 
learning method based on the structure risk minimization princi-
ple that has been shown to be very efficient in pattern recognition 
applications (Vapnik, 2000). However, the classification perform-
ance of SVM heavily depends on a proper setting of parameters. The 
RBF-SVM has two parameters: one is the RBF kernel parameter σ, 
and the other is C, which controls the trade-off between training 
error and the margin. On each round of the FSA algorithm, we 
compute the optimal parameters of RBF-SVM by evaluating its 
accuracy and diversity with the weighted training dataset through 
the bias-variance decomposition of the error in SVM (Valentini 
and Dietterich, 2002).
VoxEls sElEctIon and sVmE
The goal of this stage is to select informative voxels to aid in diagnostic 
classification. As mentioned above, the fMRI image has voxels with 
7060 non-zero meaningful voxels. The amount of non-zero voxels 
is very large compared to the number of samples. It is necessary to 
decrease the dimensionality while retaining the group discrimination 
information. First, we merge the 3 × 3 × 3 non-zero neighboring vox-
els by averaging. Thus the resultant images have 261 large voxels. In 
the second step, we apply FSA algorithm described in section “SNPs 
subset selection and SVME” to further select informative voxels and 
construct SVME. At each FSA iteration, voxels ranked with high 
discriminative values are used for training a SVM classifier. The final 
decision is a weighted ensemble of individual classifiers.
Ica componEnt ExtractIon
In prior research, ICA has been applied to the analysis of fMRI data 
to discover hidden components presenting brain activation and 
characterize their spatial locations in healthy control subjects and 
patients with schizophrenia (Calhoun et al., 2004; Sui et al., 2009). 
Forward sEquEntIal FEaturE sElEctIon (FsFs) mEthod
The FSFS algorithm is a good choice for irrelevancy removal. It 
applies independent evaluation criteria without involving any 
learning algorithm. It does not inherit any bias of a learning algo-
rithm and it is also computationally efficient (Liu, 2005). The FSFS 
algorithm starts the search from an empty SNP set. As the search 
proceeds, SNPs are added into the SNP subset one at a time. On 
each round, the best SNP for classification among unselected ones 
is chosen based on a distance measure. Distance measures are also 
known as separability, divergence, or discrimination measures. We 
try to find the SNP that can separate the patients and healthy con-
trols as far as possible. The distance measure used in this paper is 
Mahalanobis distance. The SNP subset grows until it reaches the 
full set of original SNPs. A rank list is computed according to how 
early a SNP is added into the list. Then a certain number of SNPs 
are selected to construct a candidate SNP subset for second step. 
Both the prior knowledge of the SNP dataset and experience are 
used to decide how many SNPs are selected. In order to keep more 
informative SNPs, we select about top 40% SNPs in the rank list 
to construct a candidate SNP subset. The candidate SNP subset is 
much smaller than original SNP set, but still contains unrelated 
SNPs which need to be removed.
FEaturE sElEctIVE adaboost (Fsa) mEthod
The second step is constructing a SVME by the FSA method. 
AdaBoost proposed by Freund and Schapire (1997) can be used 
in conjunction with any other iterative learning algorithms to 
improve their performance. Here, we use AdaBoost with SVM to 
build a SVM classifier ensemble. In addition, we modify AdaBoost 
to add a feature selection function, then propose a feature selec-
tive AdaBoost method. The FSA algorithm aims at training clas-
sifiers to get the best performance and selecting features with the 
best discriminating power simultaneously. The FSA algorithm is 
given below
•	Given	a	training	set	X from two classes, including m samples and 
d features per sample.
•	 Initialize	weights	for	the	m samples: D
1
(i) = 1/m.
•	For	t = 1:1:T iteration, do
- Feature selection
•	Train	a	classifier	for	each	feature	h ( , ,..., )t
k k d= 1 2 on the weighted 
samples.
•	Rank	each	feature	based	on	training	error	rate	et
k of each classi-
fier ht
k.
•	Select	 l features with the lowest et
k , and form a new training 
dataset
X x x R* * *, , , , , , , , .= ( ) ∈ ∈ − +{ } ={ }i i i l iy y i m1 1 1 2 
- Train a classifier h*t  on the weighted samples X
*.
- Compute αt t te e= −( )1 2 1/ ln /  which weighs h*t  by its classifica-
tion performance.
- Update and normalize the weighted distribution to be
 D D Z xt t t t i t ii i a y+ = −( )1( ) ( ( )/ )* exp h ( )* * , where Zt is a normaliza-
tion factor.
Frontiers in Human Neuroscience www.frontiersin.org October 2010 | Volume 4 | Article 192 | 5
Yang et al. SNP + fMRI classify
comparison, we also trained the SVMC with all 367 SNPs and 7060 
Voxels. The LOO accuracy are 0.4 (367 SNPs) and 0.675 (7060 
Voxels). The experiment results suggest that SNP and voxel selec-
tion is necessary.
At the first stage, we examined the SNPs database using the two-
step method described in section “The hybrid machine learning 
method”. After the most irrelevant SNPs filtered out from whole 
SNPs dataset using FSFS, 150 SNPs were selected. These 150 SNPs 
were then used as input features of the FSA algorithm. The number 
of iterations for FSA was set to 20 empirically since the performance 
was saturated after 20 classifiers. At each iteration the algorithm 
selected a certain number of SNPs from 150 SNPs and trained 
a SVM classifier. The number of SNPs selected in each iteration 
was estimated by the LOO algorithm on weighted training dataset. 
Those SNPs having more discrimination information are expected 
to have a high frequency of being selected. The importance of each 
SNP to the classification task can be denoted by the ratio of the 
number of times each SNPs selected over the number of iterations 
of FSA. Figure 2 shows the importance of individual SNP, and the 
most important 15 SNPs are listed in Table 2.
The basic ICA model defines a generative model for the observed 
data, with a goal of identifying hidden independent components 
from linearly mixed observations.
O A S Z W O
W A Z S
= ⋅ = ⋅
= =−
;
, ,If then1
In above equation, O is an observation matrix that can be com-
posed of measurements from MRI images. S contains the inde-
pendent components, which consists of unknown sources such as 
brain activation networks. A is a linear mixing matrix, relating the 
sources to the mixed measurements. W is an unmixing matrix. If 
W equals the inverse of A, then the Z, the estimated component 
matrix, is equivalent to S, the source matrix. There are many ICA 
algorithms based on different independence criteria. The ICA 
algorithm we use here is the infomax algorithm which attempts 
to find the W matrix through maximizing an entropy function 
(Bell and Sejnowski, 1995; Cardoso, 1997). And we use modified 
Akaike information criterion (AIC) method proposed by Li et al. 
to estimate the correct number of components (Akaike, 1974; Li 
et al., 2007). At this stage, there are five components extracted from 
the fMRI image of each sample. These five components are used as 
classification features to train a linear SVM classifier.
classIFIcatIon combInatIon
The fourth and final stage combines the results from the above three 
stages and makes a final decision via majority voting.
classIFIcatIon ExpErImEnts and rEsults
We next applied the hybrid machine learning method to the prob-
lem of separating patients from controls. All statistical results of 
our experiments are based on the LOO cross-validation method. 
Thirty-nine subjects were used for training, while one subject was 
used for testing. A total of 40 training-testing sets were imple-
mented. The performance measures used in this paper are specifi-
city, sensitivity, and accuracy. The test output of our method can 
be positive (patient) and negative (control). A true positive means 
a patient correctly diagnosed as a patient, a false positive means 
healthy people wrongly identified as sick. True negative means 
healthy people correctly identified as healthy. A false negative means 
sick people wrongly identified as healthy. The specificity, sensitivity 
and accuracy are defined as below:
Sensitivity
number of true positives
number of true positives + num
=
ber of false negatives
Specificity
number of true negative
numbe
=
r of true negative + number of false positives
Accuracy = 
number of true postives + number of true negatives
number of all samples
rEsults
Taking into account of the stochastic property of the algorithm, 
we performed the algorithm 20 times for each pair of training-
testing dataset and the average classification results in each stage 
and final combined classification model are shown in Table 1. For 
Table 1 | Performance of the classification model.
 Measures of performance
 Sensitivity Specificity Accuracy
CLASSIfICATION MODEL
SVMC with all 367 SNPs 0.4000 0.4000 0.4000
SVMC with all 7060 Voxels 0.6500 0.7000 0.6750
THE PROPOSED CLASSIfICATION MODEL
SNP-SVME 0.7175 0.7600 0.7388
Voxel-SVME 0.7875 0.8450 0.8163
ICA-SVMC 0.8000 0.8500 0.8250
Combination 0.8575 0.8875 0.8725
Figure 2 | importance of individual SNP.
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decision of SNP-SVME is especially important because this model 
makes the decision based on a totally different data source. A 
necessary and sufficient condition for an ensemble of classifiers 
to be more accurate than any of its individual members is that 
the classifiers are accurate (better than random guessing) and 
the errors are at least somewhat uncorrelated (Dietterich, 2000). 
The proposed method meets the requirement by constructing 
individual classification models from different perspectives and 
different data source.
From data shown in Table 1, we know that the proposed four-
stage method achieves better classification accuracy by combining 
genetic data and fMRI data than using either alone. The results 
indicate that even though abnormal brain function and genetic 
variation are both related to a clinical diagnosis of schizophre-
nia, they reflect different aspects of schizophrenia etiopathology, 
and cannot replace each other in terms of reflecting the disease. 
Overall, 87% accuracy was achieved, suggesting that combining 
genetic and brain functional information best represents the 
majority of symptomatic information used currently to arrive 
at a clinical diagnosis. For misclassified cases, many reasons may 
be involved including the small size of the SNP array, the rather 
simple and non-specific brain activation patterns reflected in 
the auditory stimuli paradigm and the sub-optimal sensitivity 
of the model. One observation worthy of note is that two patients 
were consistently misclassified by all classification models. This 
may be due to inaccuracy in all models, or the fact that there is 
discrepancy between biological/genetic and clinical interview-
based diagnosis.
The schizophrenia patients used in this study were chronic and 
all taking antipsychotic medication. Aware of the potential effects 
of such medication on brain function, we assume that these drugs 
had a common, general effect on all 20 patients, since most patients 
were using multiple medicines (1–5 types of medicines, and a total 
of 26 types of medicines were prescribed) at various dosages. This 
study is a proof-of-concept with a small sample size and limited 
numbers of SNPs, to demonstrate the power of combining genetics 
with brain function applied in the classification framework. For a 
full validation, the proposed method will need to be applied to a 
much larger group of subjects, including multiple SZ subcategories 
(including schizo-affective disorder), multiple clinical treatment 
group (including current-naïve subjects), and using more SNPs. 
Future work will also focus on early differentiation of sub-groups 
(which in the case of prodromal subjects can take weeks to months), 
prediction of treatment response, or early diagnosis at the time of 
first presentation.
gEnE sElEctIon
As shown in Table 2, the top 15 SNPs ranked by the proposed 
method were located in 14 genes: Among them, some are well-
known putative schizophrenia susceptibility genes, such as COMT 
(Handoko et al., 2005; Shifman et al., 2006; Nicodemus et al., 2007), 
DISC1 (St Clair et al., 1990; Hodgkinson et al., 2004; Cannon et al., 
2005; Callicott et al., 2005; Nicodemus et al., 2007; Saetre et al., 2008; 
Liu et al., 2009), MTHFR (Godfrey et al., 1990; Zintzaras, 2006; 
Gilbody et al., 2007; Jönsson et al., 2008; Roffman et al., 2008), and 
HTR3B (Maziade et al., 1995; Levinson et al., 1998; Gurling et al., 
2001; Frank et al., 2004; Yamada et al., 2006). Some are brain related 
At the second stage, the FSA selected a certain number of 
voxels that containing the most discriminating information 
from 261 large voxels and trained a SVM at each iteration. The 
number of voxels to be selected at each iteration was estimated by 
the LOO algorithm with weighted training dataset used in that 
iteration. The importance of each voxel to the classification task 
can be denoted by the ratio of the number of times each voxel 
selected over the number of iterations of FSA. Figure 3 shows 
the location of selected voxels in the brain and their impor-
tance. The volume of each region represents the importance of 
voxels. Yellow indicates the highly important region, followed 
by orange and red. Table 3 lists the anatomical brain regions 
of selected voxels.
dIscussIon
classIFIcatIon rEsults
In the method described, three kinds of classification information 
were extracted from genetic and fMRI data in order to classify 
schizophrenia and healthy control subjects using three models: 
SNP-SVME, Voxel-SVME, and ICA-SVMC. Among them, Voxel-
SVME and ICA-SVMC both extract information from fMRI data, 
while only SNP-SVME extracts classification information from 
SNP data. FMRI data have more weight than SNP data in the 
proposed method for two reasons: (a) fMRI images contain more 
discriminating information than SNP data, due to the fact that 
brain function is logically closer to the expression of mental ill-
ness symptoms and as expected the fMRI classification models 
performed better than SNP classification model in our experi-
ments; (b) although Voxel-SVME and ICA-SVMC models are 
both constructed with fMRI data, the two models present dis-
criminating information from different perspectives. This does 
not imply that the SNP classification model is unnecessary. In 
fact, when the two fMRI models disagree with each other, the 
 Table 2 | Top 15 SNPs.
SNP gene
rs6136 SELP: selectin P (granule membrane 
 protein 140 kDa, antigen CD62)
rs737865 COMT: catechol-O-methyltransferase
rs7072137 GAD2: glutamic acid decarboxylase 2
rs1176744 HTR3B: 5-hydroxytryptamine (serotonin) receptor 3B
rs821616 DISC1: disrupted in schizophrenia 1
rs11188092 CYP2C19: cytochrome P450, family 2, subfamily C, 
 polypeptide 19
rs3771892 TNFAIP6: tumor necrosis factor alpha-induced protein 6
rs1128503 ABCB1: ATP-binding cassette, sub-family B (MDR/TAP), 
 member 1
rs2066470 MTHFR: 5,10-methylenetetrahydrofolate reductase (NADPH)
rs2020933 SLC6A4: solute carrier family 6 (neurotransmitter transporter, 
 serotonin), member 4
rs2192752 IL1R1: interleukin 1 receptor, type I
rs2298122 DRD1IP: dopamine receptor D1 interacting protein
rs2276307 HTR3B: 5-hydroxytryptamine (serotonin) receptor 3B
rs3758947 ABCC8: ATP-binding cassette, sub-family C, member 8
rs11212515 ACAT1: acetyl-coenzyme A acetyl transferase 1
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Figure 3 | The location of selected voxels.
Table 3 | The detail region of selected voxels.
Area Broadmann area L/r volume (cc) L/r importance: value (x,y,z)
Postcentral gyrus : 3: 5: 2: 7 0.7/0.6 1 (−24,−29,71)/1 (18,−34,71)
Precentral gyrus : 4: 6: 44: 9 0.9/1.0 1 (−12,−29,71)/1 (18,−29,71)
Paracentral lobule : 6: 4: 5: 31 0.2/0.2 1 (0,−34,71)/1 (6,−29,71)
Cingulate gyrus : 31: 32: 24 1.8/1.6 0.341 (−6,−42,44)/0.341 (12,−42,44)
Superior parietal lobule : 7 0.3/0.2 0.341 (−30,−47,44)/0.341 (30,−53,44)
Inferior parietal lobule : 40 0.6/0.4 0.341 (−30,−42,44)/0.341 (48,−42,44)
Precuneus : 7: 31 1.0/0.9 0.341 (0,−42,44)/0.341 (30,−42,44)
Medial frontal gyrus : 11: 32: 10: 6: 9 1.1/1.1 0.268 (−6,49,−15)/0.268 (6,49,−15)
Superior temporal gyrus : 38: 22:*: 41: 42 1.0/1.0 0.268 (−48,20,−14)/0.268 (48,20,−14)
Middle frontal gyrus : 11: 10: 47: 6: 46: 9 3.9/2.3 0.268 (−42,49,−15)/0.268 (24,37,−14)
Inferior frontal gyrus : 47: 11:*: 46: 45: 9: 13 3.2/1.9 0.268 (−36,14,−8)/0.268 (42,20,−14)
Superior frontal gyrus : 11: 10: 9 1.0/0.6 0.268 (−18,60,−16)/0.268 (18,60,−16)
Anterior cingulate : 32: 24 0.2/0.3 0.036 (−6,39,23)/0.121 (12,43,−10)
Middle temporal gyrus : 22: 19: 21: 20 0.8/0.6 0.024 (−53,−32,4)/0.024 (65,−32,4)
Caudate : 0.1/0.2 0.024 (−36,−32,4)/0.024 (36,−32,4)
Transverse temporal gyrus : 42: 41 0.2/0.3 0.012 (−59,−14,9)/0.012 (59,−14,9)
Posterior cingulate : 31:*: 30 0.2/0.1 0.012 (−30,−60,17)/0.012 (30,−66,17)
Insula : 13 0.1/0.2 0.012 (−30,27,18)/0.073 (30,26,1)
Cuneus : 19: 18: 30: 17: 23 0.8/0.7 0.012 (−18,−89,24)/0.012 (12,−95,24)
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